KeyBank National Association
CYTK icon

KeyBank National Association’s Cytokinetics CYTK Stock Holding History

KeyBank National Association’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-75,692
Closed -$2.53M – 1082
2021
Q3 		$2.53M Buy
+75,692
New +$2.23M 0.01% 347
2018
Q4 		– Sell
-21,864
Closed -$215K – 957
2018
Q3 		$215K Sell
21,864
-6,453
-23% -$51.8K ﹤0.01% 989
2018
Q2 		$235K Buy
28,317
+6,552
+30% +$54.5K ﹤0.01% 941
2018
Q1 		$157K Hold
21,765
– – ﹤0.01% 1007
2017
Q4 		$177K Buy
21,765
+5,464
+34% +$62K ﹤0.01% 1000
2017
Q3 		$236K Sell
16,301
-7,187
-31% -$98.2K ﹤0.01% 981
2017
Q2 		$284K Sell
23,488
-1,130
-5% -$15.7K ﹤0.01% 960
2017
Q1 		$316K Sell
24,618
-15,586
-39% -$182K ﹤0.01% 959
2016
Q4 		$488K Sell
40,204
-3,964
-9% -$42.1K ﹤0.01% 818
2016
Q3 		$405K Hold
44,168
– – ﹤0.01% 888
2016
Q2 		$419K Hold
44,168
– – ﹤0.01% 839
2016
Q1 		$311K Hold
44,168
– – ﹤0.01% 921
2015
Q4 		$462K Sell
44,168
-9,477
-18% -$93K ﹤0.01% 800
2015
Q3 		$359K Hold
53,645
– – ﹤0.01% 892
2015
Q2 		$360K Hold
53,645
– – ﹤0.01% 953
2015
Q1 		$364K Sell
53,645
-11,416
-18% -$85.3K ﹤0.01% 953
2014
Q4 		$521K Sell
65,061
-6,334
-9% -$27.2K ﹤0.01% 852
2014
Q3 		$251K Buy
71,395
+30,846
+76% +$130K ﹤0.01% 1105
2014
Q2 		$194K Buy
40,549
+5,519
+16% +$33.7K ﹤0.01% 1215
2014
Q1 		$333K Sell
35,030
-10,100
-22% -$91.3K ﹤0.01% 1046
2013
Q4 		$293K Buy
45,130
+18,212
+68% +$120K ﹤0.01% 1089
2013
Q3 		$204K Buy
+26,918
New +$289K ﹤0.01% 1166

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KeyBank National Association's CYTK Position: Q4 2021 in Review

KeyBank National Association sold out of Cytokinetics (CYTK) in Q4 2021, closing a stake of 75,692 shares — an estimated $2.53M sold.

KeyBank National Association first reported a position in CYTK in Q3 2013 and held it in 22 quarters. The position peaked at $2.53M in Q3 2021. 250 funds tracked by Wall St. Rank hold CYTK as of Q4 2021.

  • KeyBank National Association reported no remaining Cytokinetics position as of Q4 2021 after selling out during the quarter.
  • KeyBank National Association sold 75,692 Cytokinetics shares in Q4 2021, an estimated $2.53M.
  • KeyBank National Association first reported a position in Cytokinetics in Q3 2013 and held it in 22 quarters.
  • KeyBank National Association's Cytokinetics position peaked at $2.53M in Q3 2021.
  • 250 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2021.

Based on KeyBank National Association's 13F filing for Q4 2021, filed 7 Feb 2022.